
RENHE PHARMACY CO.,LTD — Investor Relations & Filings
Renhe Pharmacy Co., Ltd. specializes in the research, development, manufacturing, and distribution of pharmaceutical products and health-related commodities. The company maintains a diverse portfolio encompassing over-the-counter (OTC) medications, traditional Chinese medicines (TCM), health supplements, and personal care items. Its core product lines address various therapeutic areas, including respiratory health, digestive disorders, gynecology, and pediatrics. Renhe is recognized for its established brand equity, operating well-known labels such as Renhe, Youka, and Fuyan. The company integrates modern pharmaceutical technology with traditional medicinal practices to produce high-quality healthcare solutions. Its operations are supported by a comprehensive supply chain and an extensive marketing network, focusing on providing accessible healthcare products to a broad consumer base.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事专门会议工作制度(2025年10月) | 2025-10-13 | Chinese | |
| 总经理工作细则(2025年10月) | 2025-10-13 | Chinese | |
| 证券投资管理制度(2025年10月) | 2025-10-13 | Chinese | |
| 信息披露暂缓和豁免管理制度(2025年10月) | 2025-10-13 | Chinese | |
| 审计委员会议事规则(2025年10月) | 2025-10-13 | Chinese | |
| 提名委员会议事规则(2025年10月) | 2025-10-13 | Chinese |
Browse filings by year
28 years- 2026 28 filings
- 2025 99 filings
- 2024 77 filings
- 2023 79 filings
- 2022 80 filings
- 2021 115 filings
- 2020 108 filings
- 2019 69 filings
- 2018 43 filings
- 2017 43 filings
- 2016 93 filings
- 2015 100 filings
- 2014 74 filings
- 2013 106 filings
- 2012 114 filings
- 2011 79 filings
- 2010 60 filings
- 2009 66 filings
- 2008 40 filings
- 2007 73 filings
- 2006 79 filings
- 2005 38 filings
- 2004 24 filings
- 2003 26 filings
- 2002 18 filings
- 2001 6 filings
- 1998 1 filing
- 1996 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42929886 | 独立董事专门会议工作制度(2025年10月) | 2025-10-13 | Chinese | ||
| 42929831 | 总经理工作细则(2025年10月) | 2025-10-13 | Chinese | ||
| 42929800 | 证券投资管理制度(2025年10月) | 2025-10-13 | Chinese | ||
| 42929773 | 信息披露暂缓和豁免管理制度(2025年10月) | 2025-10-13 | Chinese | ||
| 42929714 | 审计委员会议事规则(2025年10月) | 2025-10-13 | Chinese | ||
| 42929685 | 提名委员会议事规则(2025年10月) | 2025-10-13 | Chinese | ||
| 42929656 | 募集资金管理制度(2025年10月) | 2025-10-13 | Chinese | ||
| 42929607 | 信息披露管理制度(2025年10月) | 2025-10-13 | Chinese | ||
| 42929580 | 年报信息披露重大差错责任追究制度(2025年10月) | 2025-10-13 | Chinese | ||
| 42929548 | 子公司管理办法(2025年10月) | 2025-10-13 | Chinese | ||
| 42929507 | 薪酬与考核委员会议事规则(2025年10月) | 2025-10-13 | Chinese | ||
| 42929476 | 股东会议事规则(2025年10月) | 2025-10-13 | Chinese | ||
| 42929434 | 关联交易管理制度(2025年10月) | 2025-10-13 | Chinese | ||
| 42929389 | 董事会秘书工作细则(2025年10月) | 2025-10-13 | Chinese | ||
| 42929364 | 委托理财管理制度(2025年10月) | 2025-10-13 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
RENHE PHARMACY CO.,LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for RENHE PHARMACY CO.,LTD (id: 53730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.